Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Massari, Francesco
Item TypeName
Concept Neoplastic Stem Cells
Concept Cell Adhesion
Concept Dendritic Cells
Concept Cell Cycle Proteins
Concept Carcinoma, Transitional Cell
Concept Cell Differentiation
Concept Cell Proliferation
Concept Carcinoma, Renal Cell
Concept Neoplastic Cells, Circulating
Concept Cell Line, Tumor
Concept Cell Count
Academic Article Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Academic Article Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.
Academic Article Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Academic Article Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma.
Academic Article Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
Academic Article Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program.
Academic Article Designing novel immunocombinations in metastatic renal cell carcinoma.
Academic Article An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer.
Academic Article Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.
Academic Article Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice.
Academic Article INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.
Academic Article Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
Academic Article Tivozanib for the treatment of renal cell carcinoma.
Academic Article Circulating tumor cells in genitourinary tumors.
Academic Article Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti-PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269-76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation.
Academic Article Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution.
Academic Article Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Academic Article The prospect of precision therapy for renal cell carcinoma.
Academic Article Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies.
Academic Article Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer.
Academic Article Liquid biopsies in renal cell carcinoma with focus on epigenome analysis.
Academic Article Emerging Immunotargets and Immunotherapies in Prostate Cancer.
Academic Article Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy.
Academic Article Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer.
Academic Article New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?
Academic Article Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives.
Academic Article Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.
Academic Article Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view.
Academic Article Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma.
Academic Article Editorial: Emerging Immunotargets in Genitourinary Tumors.
Academic Article Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
Academic Article Re: Michael B. Atkins, Elizabeth R. Plimack, Igor Puzanov, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-randomised, Open-label, Dose-finding, and Dose-expansion Phase 1b Trial. Lancet Oncol 2018;19:405-15.
Academic Article Optimizing renal function and outcome of patients with cT2 renal cell carcinoma.
Academic Article Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research.
Academic Article Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417-27: CARMENA Trial: Is This the End of Cytoreductive Nephrectomy in Patients with Clear-cell Renal Cell Carcinoma?
Academic Article Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer.
Academic Article Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.
Academic Article Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
Academic Article BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies.
Academic Article Metabolic alterations in renal cell carcinoma.
Academic Article Immunotherapy and Radiation Therapy in Renal Cell Carcinoma.
Academic Article Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients.
Academic Article PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay.
Academic Article Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer.
Academic Article PD-L1 Inhibitors for the Treatment of Prostate Cancer.
Academic Article Metabolic phenotype of bladder cancer.
Academic Article Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.
Academic Article Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
Academic Article Toward a genome-based treatment landscape for renal cell carcinoma.
Academic Article Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
Academic Article Emerging Immunotargets in Metastatic Renal Cell Carcinoma.
Academic Article Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.
Academic Article Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma.
Academic Article Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3: Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell Carcinoma.
Academic Article Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma.
Academic Article Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort.
Academic Article Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors.
Academic Article A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
Academic Article Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
Academic Article Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma.
Academic Article Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions.
Academic Article Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges.
Academic Article Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?
Academic Article Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor.
Academic Article Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
Academic Article Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma.
Academic Article Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis.
Academic Article Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma.
Academic Article Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Academic Article Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
Academic Article Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.
Academic Article Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
Academic Article Emerging Immunotargets in Bladder Cancer.
Academic Article Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer.
Academic Article An Overview of Emerging Immunotargets of Genitourinary Tumors.
Academic Article The route to personalized medicine in bladder cancer: where do we stand?
Academic Article The origin of prostate metastases: emerging insights.
Academic Article New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials.
Academic Article Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder.
Academic Article Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors.
Academic Article Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy.
Academic Article Is There a Role for Immunotherapy in Prostate Cancer?
Academic Article Tp53 and its potential therapeutic role as a target in bladder cancer.
Academic Article Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States.
Academic Article Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications.
Academic Article Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
Academic Article Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials.
Academic Article Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis.
Academic Article A brand-new CAR for macrophages: is it time to fire up the engines of a new era for the treatment of renal cell carcinoma?
Academic Article Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?
Academic Article Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials.
Academic Article Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma.
Academic Article Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review.
Academic Article Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysis.
Academic Article Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.
Academic Article Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages.
Academic Article Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis.
Academic Article Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Academic Article Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis.
Academic Article The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?
Academic Article Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials.
Academic Article Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
Academic Article An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma.
Academic Article Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study.
Academic Article Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views.
Academic Article Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.
Academic Article Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trials.
Concept Cell Plasticity
Concept Cell-Free Nucleic Acids
Concept Costimulatory and Inhibitory T-Cell Receptors
Concept Programmed Cell Death 1 Receptor
Academic Article Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis.
Academic Article Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
Academic Article Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors.
Academic Article Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison.
Academic Article Assessing PD-L1 status in mRCC treated with first-line immune-based combinations: a meta-analysis.
Search Criteria
  • Somatostatin Secreting Cells